• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

MARS Bioimaging Secures $15M to Scale World’s First Portable Spectral CT Scanners

by Jasmine Pennic 01/14/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
MARS Bioimaging’s Group CEO Dr Ojas Mahapatra (left) with Chairman Chris Stoelhorst

What You Should Know

– MARS Bioimaging, a New Zealand–headquartered pioneer in medical imaging, secures $15M in Series A funding round. Led by Pacific Channel. 

– The capital will be used to scale the commercial adoption of the world’s first portable spectral photon-counting CT scanners—technology that delivers high-resolution, 3D color images to the point of care.

The Spectral Shift: 3D Color vs. Black-and-White

Traditional CT scans are typically low-resolution, black-and-white images that often struggle to differentiate between similar materials. MARS Bioimaging’s technology represents a generational leap in diagnostic capability.

Key MARS Bioimaging features include: 

Advanced Material Differentiation: The scanners visualize soft tissue, bone, blood vessels, and metallic implants in extraordinary detail by measuring the energy levels of individual X-ray photons.

No Contrast Required: Unlike traditional imaging, MARS can achieve this high-fidelity material differentiation without the need to inject X-ray contrast agents into the patient.

Portable and Accessible: The MARS Extremity and Microlab systems are designed for point-of-care use, bringing premium imaging out of the central radiology department and into the community.

Global Expansion: Scaling into the U.S. and India

The Series A round was raised in two tranches, with $7.4M in new capital closed in 2026. The company attracted a diverse group of international investors, including a Singapore-based med-sector firm and a Swiss investor secured through New Zealand’s Active Investor Plus (AIP) program.

“We’re on a mission to transform point-of-care diagnostic solutions for patients and healthcare providers, and advance premium imaging in the community,” said Dr Ojas Mahapatra, Group CEO, MARS Bioimaging. “This investment allows us to build our market capability, including expanding our sales and business development teams in New Zealand and the United States. Our new investors will also help open access to emerging markets, while NZTE will continue to be an important partner supporting our international expansion.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |